NCT03641508View on ClinicalTrials.gov

Long Term Effectiveness of Trigger Finger Injections With Triamcinolone vs. Dexamethasone

PHASE4CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Trigger Finger Disorder
Interventions
DRUG

Triamcinolone

Triamcinolone acetonide (Kenalog; 10 mg/mL; insoluble). This will be mixed with 1% lidocaine without epinephrine

DRUG

Dexamethasone

dexamethasone sodium phosphate (Decadron; 4 mg/mL; soluble). Again, this will be mixed with 1% lidocaine without epinephrine

Trial Locations (1)

52242

University of Iowa, Iowa City

All Listed Sponsors
lead

Ericka Lawler

OTHER

NCT03641508 - Long Term Effectiveness of Trigger Finger Injections With Triamcinolone vs. Dexamethasone | Biotech Hunter | Biotech Hunter